SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX)
AFFX 14.010.0%Apr 1 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Lokness who wrote (831)4/24/1999 12:10:00 AM
From: BradleyMarshall  Read Replies (1) of 1728
 
RE: What is microfluidics and why will it revolutionize biotech>

OK, let me give it a try. Microfluidics is the manipulation of extremely small volumes. (ie nanoliters) Current molecular bio techniques use measurements of minimally 1 microliter or so (1000 times larger than a nanoliter.) This is done manually by people withg pippettes.

Microfluidics is generally done by etching micro canals into glass surfaces with micropumps that move the liquid around. The advantages of this approach are 1) Much smaller sample sizes needed. This saves money and precious tissue samples. 2) No humans are needed. This dramatically increases accuracy and decreases time spent and thus costs of using these systems. Additionally, the less labor involved the more likely a doctor is to use a chip in a clinical setting.

Now my question: Does anyone know how much SAffx is doing with microfluidics?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News